We are all being lied to.
There is NO approved Covid-19 vaccine in the USA.
August 23, 2021
On August 23, 2020, the FDA and corporate media declared that the FDA fully approved the Pfizer Covid-19 vaccine, which is -as always- only part of the truth.
The truth is that on August 23, 2021, the FDA approved the manufacturing of Pfizer/BioNTech’s “Comirnaty” vaccine in Germany, but this vaccine is NOT available in the US! It is the same vaccine as Pfizer’s Covid-19 vaccine available in the US. However, FDA has only extended the EUA for the Pfizer vaccine in the USA.
The ‘approved’ version ‘Comirnaty’ manufactured by BioNTech in Germany, which is NOT available in the USA also still requires 13 studies which will go on until 2027. Pfizer can be held liable for any adverse effects, if they administer this “approved”, but not in the US available Comirnaty vaccine.
In Europe, the Comirnaty vaccine by BioNTech Germany has only the “Conditional marketing authorization” which has been renewed on November 3, 2021, for one more year. The same is true for AstraZeneca, Moderna, and Janssen in Europe and the US.
On August 23, 2021, the FDA RE-ISSUED the EUA for the Pfizer Covid-19 vaccine, which has been administered since December 2020 in the USA. It still has the EUA and is in stock in huge amounts. Pfizer can not be held liable for this experimental vaccine.
In addition, the booster shots still just have the EUA, as well as the shots for children under the age of 16.
According to the US Issuance of AuthorizationLetter to Pfizer, it has not been approved, but is “an investigational vaccine not licensed for any indication.”
August 23, 2021
Re-issuance of the EUA for Pfizer Covid-19 Vaccine to Pfizer Inc, Collegeville, PA / USA ( Unfortunately the original letter from 8/23/21 is no longer available on the FDA page)
August 23, 2021
(needs 13 studies/ final report submission between 2023 to May 2027)
Do you notice that there are no places of manufacturing listed in the document?
To this day, there is no approved ‘Comirnaty” available in the USA.
In the Immunization Information Systems (IIS) of the CDC, the approved “Comirnaty” is listed with the NDC Code 00069-1000-02 and 00069-1000-01.
It also explicitly says:
Searching the NDC / National Drug Codes List for 00069-1000-01 and 00069-1000-02 the results are shown as:
“No results found”
Look up 00069-1000-01 at the NDC
Look up 00069-1000-02 at the NDC
Since there is no NDC code the FDA-approved “Comirnaty” vaccine can still not be ordered in the USA.
August 22, 2021
On August 22, 2021, the FDA agreed in their letter to Pfizer to the extension of the shelf-life of the Pfizer COVID-19 Vaccine from 6 to 9 months. Therefore, the strategy surely is to first use up the existing supplies, for which Pfizer can not be held liable, because it just has the EUA. Whether we still need any of these vaccines after May 2022 is highly questionable.
September 14, 2021
On September 14, 2021 the Assistant Secretary of Defense wrote the following Memorandum:
Mandatory Vaccination of Service Members using Pfizer-BioNTech Covid-19 and Comirnaty COVID-19 Vaccines and states the following:
Per FDA guidance, these two vaccines are “interchangeable” and DoD health care providers should “use doses distributed under the EUA to administer the vaccination series as if the doses were the licensed vaccine.”
By the way – the Pfizer/BioNTech Vocid-19 Vaccine Comirnaty has also only been granted conditional marketing authorization in the EU, the equivalent to the EUA in the USA. The EU conditional marketing authorization for Comirnaty has been renewed in November 2021.
Therefore the Pfizer/BioNTech Vocid-19 Vaccine Comirnaty is nowhere available as an approved vaccine.
We are all being lied to.
P.S.
August 31, 2021
On August 31, 2021, two of the top executives involved in vaccine research and testing at the Food and Drug Administration / FDA left the agency. They complained that the CDC had seized the right to make decisions.
August 31, 2021
Marion Gruber, Phil Krause, FDA’s top vaccine regulators, stepped down.
Two of the top executives involved in vaccine research and testing at the Food and Drug Administration / FDA left the agency. Marion Gruber and Phil Krause were the director and deputy director, respectively, of the agency’s Office of Vaccines Research & Review.
The pair complained that the CDC, and specifically its Advisory Committee on Immunization (ACIP), had seized the right to make decisions that had previously been left up to the FDA. The researchers were also supposedly upset with Marks for not standing up for them against the CDC. The Biden administration’s decision to announce a third round of mRNA “booster” shots without consulting them was merely the last straw.
All information is deemed accurate but not guaranteed and should be independently verified.
